ZED-3269

N/A

Report date: 2023/12/19 14:31:20
NME

Base Information

Drug NameZED-3269
Drug Alias NameZED-3269ZED3269
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransglutaminases inhibitors
TargetsTransglutaminases
Therapy Area/IndicationsDiabetic NephropathiesIdiopathic Pulmonary FibrosisLiver Cirrhosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZedira GmbH
China Registration ClassN/A

Develop Information

Active CompaniesZedira GmbH
Inactive CompaniesN/A
Active IndicationsDiabetic NephropathiesIdiopathic Pulmonary FibrosisLiver Cirrhosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A